Communities Nationwide Come Together for Blood Cancer Awareness and Support

Communities Unite for Blood Cancer Patients

As communities from all over the United States join forces, Blood Cancer United is launching its 37th annual Visionaries of the Year campaign, a philanthropic initiative designed to gather local leaders and inspire them to fundraise for blood cancer research and patient support. This vibrant 10-week challenge not only aims to raise funds but also amplifies awareness around the struggles faced by individuals and families affected by blood cancers.

The Visionaries of the Year campaign stands as a testament to dedication, compassion, and the drive for change. Participants in this campaign often have personal stories that fuel their passion. Such motivations might stem from witnessing a loved one's battle against blood cancer, or it could be inspired by an understanding of the challenges that families endure during such difficult times. This heartfelt involvement positions the campaign as a powerful platform for community engagement.

In the previous year, Lee-Lee Ellis, hailing from Washington, D.C., was honored with the title of National Visionary of the Year after impressively raising over $466,000 for the cause. Ellis emphasized the collective strength seen in fundraisers, stating, "This campaign showed me how powerful we can be when we come together for something bigger than ourselves. Every dollar, every conversation, every story shared—it all brings us closer to a world without blood cancer."

Blood Cancer United has a rich history in advocating for change, having contributed more than $2 billion to groundbreaking research over the last 77 years. The organization underscores its commitment to improving patients' quality of life and increasing the efficacy of treatments available to them. "Together, our incredible Visionaries of the Year fundraisers and volunteers are driving progress toward better treatments and vital support for those who need it most," expressed Coker Powell, the Executive Vice President, Chief Revenue Officer at Blood Cancer United.

The current class of Visionaries is resonating in the spotlight, with their stories and commitments featured on Forbes.com. This year's campaign is more than just fundraising; it’s about building a community of advocates dedicated to finding a cure for blood cancer and enhancing the lives of those impacted.

Participation in the Visionaries of the Year campaign not only offers individuals the chance to contribute financially but also to take part in a greater movement toward a future free from blood cancer. Each fundraiser plays a pivotal role in this mission, making a difference through their networks and communities.

Blood Cancer United, formerly known as The Leukemia & Lymphoma Society, stands as the world's largest nonprofit organization wholly focused on addressing the needs of blood cancer patients. Founded in 1949, it has continually adapted its strategies to support those affected by over 100 different types of blood cancer. The organization doesn’t just offer financial aid; it provides free resources and personalized support to patients while advocating for affordable and accessible healthcare options on both state and national levels.

If you want to get involved or seek assistance related to blood cancer, visit www.BloodCancerUnited.org/Visionaries. Additionally, personal support from their specialists is available for patients. You can contact them via (800) 955-4572 during the week from 9 a.m. to 9 p.m. ET. Engage with Blood Cancer United on platforms like Facebook, X, Instagram, LinkedIn, TikTok, and Threads to stay updated and supportive of their initiatives.

Everyone can play a part in this journey toward curing blood cancer. Whether you choose to participate, donate, or spread the word, your contribution can significantly impact the lives of many. Together, let’s forge ahead in creating a future where blood cancer is no longer a threat. The power of community can inspire change, uplift those struggling, and ultimately lead to a breakthrough in treatment and support for blood cancer patients.